On Wednesday, the Nevada Legislature Assembly Select Committee on End-Of-Life Care heard a bill that seeks to legalize ...
Norman Miller, a Pulitzer Prize winning journalist who headed national coverage at the Los Angeles Times, died at the age of ...
The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
Sanofi's Qfitlia gains FDA approval, offering fewer injections in hemophilia care. Check out my recommendation for SNY stock.
Jim Cramer in a latest program on CNBC talked about the winning sectors so far this year and said the trends show a "strange" ...
The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep ...
Blagosklonny goes on to write that even though rapamycin may reverse some manifestations of aging, it is more effective at ...
Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...
Columnist Caroline Gainer's first kettlebell workout went far better than she expected. Sometimes trying something new pays ...
Based on the advice from the FDA at the meeting, Connect plans to begin enrolling patients in these trials during the second quarter of this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results